Vitamin D supplementation: Guidelines and evidence for subclinical deficiency

Current Opinion in Gastroenterology

Volumn 28, Issue 2, 2012, Pages 139-150

  Pramyothin, Pornpoj ^a,b   Holick, Michael F ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

25 hydroxyvitamin D; dietary reference intake; inflammatory bowel disease; Recommended Dietary Allowance; vitamin D; vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

AGE; BARIATRIC SURGERY; BERYLLIOSIS; BONE DENSITY; BONE MINERALIZATION; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COCCIDIOIDOMYCOSIS; CROHN DISEASE; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DOSE RESPONSE; ENTERITIS; FALLING; FRACTURE; HISTOPLASMOSIS; HUMAN; LIVER FAILURE; LYMPHOMA; MAINTENANCE THERAPY; MUSCLE WEAKNESS; OBESITY; OSTEOMALACIA; OSTEOPOROSIS; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSE; RADIATION ENTEROPATHY; REVIEW; RICKETS; RISK REDUCTION; SARCOIDOSIS; SECONDARY HYPERPARATHYROIDISM; SEX DIFFERENCE; STOMACH BYPASS; SYSTEMATIC REVIEW (TOPIC); TUBERCULOSIS; UNSPECIFIED SIDE EFFECT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION;

ASYMPTOMATIC DISEASES; BONE DISEASES; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; ERGOCALCIFEROLS; HUMANS; NUTRITION POLICY; PRACTICE GUIDELINES AS TOPIC; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84858038425     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32835004dc     Document Type: Review

References (50)

1. IOM. Dietary Reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: The National Academies Press; 1997.
2. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-281.
3. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911-1930.
4. IOM. Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press; 2011. The new IOM report updates the IOM report of 1997.
5. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96:53-58.
6. Aloia JF. The 2011 report on dietary reference intake for vitamin D: where do we go from here? J Clin Endocrinol Metab 2011; 96:2987-2996.
7. Heaney RP, Holick MF. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 2011; 26:455-457.
8. Holick MF. The D-batable Institute of Medicine report: A D-lightful perspective. Endocr Pract 2011; 17:143-149.
9. Cranney A, Horsley T, O'Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evidence report/technology assessment no. 158 (prepared by the University of Ottawa Evidence-based Practice Center). AHRQ Publication No. 07-E013. Rockville, MD: Agency for Healthcare Research and Quality; 2007.
10. Chung M, Balk E, Brendel M, et al. Vitamin D and calcium: A systematic review of health outcomes. Evidence report no. 183 (prepared by the Tufts Evidencebased Practice Center). AHRQ Publication No. 09-E015. Rockville, MD: Agency for Healthcare Research and Quality; 2009.
11. Priemel M, von Domarus C, Klatte TO, et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 2010; 25:305-312.
12. Maxmen A. Nutrition advice: The vitamin D-lemma. Nature 2011; 475:23-25.
13. Holick MF, Siris ES, Binkley N, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005; 90:3215-3224. (Pubitemid 41014278)
14. Durazo-Arvizu RA, Dawson-Hughes B, Sempos CT, et al. Three-phase model harmonizes estimates of the maximal suppression of parathyroid hormone by 25-hydroxyvitamin D in persons 65 years of age and older. J Nutr 2010;140:595-599.
15. Aloia JF, Talwar SA, Pollack S, et al. Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr 2006; 84:602-609. (Pubitemid 44713411)
16. Sai AJ, Walters RW, Fang X, Gallagher JC. Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab 2011; 96:E436-E446.
17. Salameh W, Holmquist B, Lee G, et al. Quantification of serum 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 using high-performance liquid chromatography, tandem mass spectrometry (LC-MS/MS): Correlation with PTH and other assay methods. Poster at the 2010 Endocrine Society Meeting (P1-181). Endocr Rev 2010; 31:S238.
18. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003; 22:142-146. (Pubitemid 36417827)
19. Aloia JF, Chen DG, Yeh JK, Chen H. Serum vitamin D metabolites and intestinal calcium absorption efficiency in women. Am J Clin Nutr 2010; 92:835-840.
20. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or 60 y. Am J Clin Nutr 2004; 80:752-758. (Pubitemid 41115542)
21. Pfeifer M, Begerow B, Minne HW, et al. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 2009; 20:315-322.
22. Michael YL, Whitlock EP, Lin JS, et al. Primary care-relevant interventions to prevent falling in older adults: A systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2010; 153:815-825.
23. Murad MH, Elamin KB, Abu Elnour NO, et al. The effect of vitamin D on falls: A systematic review and meta-analysis. J Clin Endocrinol Metab 2011; 96:2997-3006.
24. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: A randomized controlled trial. JAMA 2010; 303:1815-1822.
25. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: A population-based study of younger and older adults. Am J Med 2004; 116:634-639. (Pubitemid 38490539)
26. Cauley JA, Parimi N, Ensrud KE, et al. Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men. J Bone Miner Res 2010; 25:545-553.
27. Cauley JA, Lacroix AZ, Wu L, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008; 149:242-250.
28. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327:1637-1642.
29. The DIPART (vitamin D Individual Patient Analysis of Randomized Trials) Group. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 2010; 340:b5463.
30. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006; 354:669-683. (Pubitemid 43247138)
31. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, et al. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int 2010; 21:1121-1132.
32. Jeans PC. Vitamin D. JAMA 1950; 143:177-181.
33. Heaney RP, Davies KM, Chen TC, et al. Human serum 25- hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003; 77:204-210. (Pubitemid 36015393)
34. Holick MF, Biancuzzo RM, Chen TC, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008; 93:677-681. (Pubitemid 351398538)
35. Holick MF, Chen TC. Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 2008; 87:1080S-1086S. (Pubitemid 351549267)
36. Leslie WD, Miller N, Rogala L, Bernstein CN. Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: The Manitoba IBD Cohort Study. Am J Gastroenterol 2008; 103:1451-1459. (Pubitemid 351813899)
37. Aasheim ET, Bjorkman S, Sovik TT, et al. Vitamin status after bariatric surgery: A randomized study of gastric bypass and duodenal switch. Am J Clin Nutr 2009; 90:15-22.
38. Farraye FA, Nimitphong H, Stucchi A, et al. Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease. Inflamm Bowel Dis 2011; 17:2116-2121.
39. Lin E, Armstrong-Moore D, Liang Z, et al. Contribution of adipose tissue to plasma 25-hydroxyvitamin D concentrations during weight loss following gastric bypass surgery. Obesity (Silver Spring) 2011; 19:588-594.
40. Pramyothin P, Biancuzzo RM, Lu Z, et al. Vitamin D in adipose tissue and serum 25-hydroxyvitamin D after Roux-en-Y gastric bypass. Obesity (Silver Spring) 2011; 19:2228-2234.
41. Gordon CM, Williams AL, Feldman HA, et al. Treatment of hypovitaminosis D in infants and toddlers. J Clin Endocrinol Metab 2008; 93:2716-2721. (Pubitemid 352008541)
42. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004; 89:5387-5391. (Pubitemid 39518413)
43. Heaney RP, Recker RR, Grote J, et al. Vitamin D3 is more potent than vitamin D2 in humans. J Clin Endocrinol Metab 2011; 96:E447-E452.
44. Pietras SM, Obayan BK, Cai MH, Holick MF. Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. Arch Intern Med 2009; 169:1806-1808.
45. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95:471-478.
46. Shapses SA, Manson JE. Vitamin D and prevention of cardiovascular disease and diabetes: why the evidence falls short. JAMA 2011; 305:2565-2566.
47. O'Keefe JH, Lavie CJ, Holick MF. Vitamin D supplementation for cardiovascular disease prevention. JAMA 2011; 306:1546-1547; author reply 1547-1548.
48. Dong Y, Stallmann-Jorgensen IS, Pollock NK, et al. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab 2010; 95:4584-4591.
49. Elamin MB, Abu Elnour NO, Elamin KB, et al. Vitamin D and cardiovascular outcomes: A systematic review and meta-analysis. J Clin Endocrinol Metab 2011; 96:1931-1942.
50. Manson JE, Bassuk SS, Lee IM, et al. The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 2011. [Epub ahead of print]